Literature DB >> 21497190

Development of machine learning models of β-cyclodextrin and sulfobutylether-β-cyclodextrin complexation free energies.

Alexei Merzlikine1, Yuriy A Abramov, Stacy J Kowsz, V Hayden Thomas, Takashi Mano.   

Abstract

A new set of 142 experimentally determined complexation constants between sulfobutylether-β-cyclodextrin and diverse organic guest molecules, and 78 observations reported in literature, were used for the development of the QSPR models by the two machine learning regression methods - Cubist and Random Forest. Similar models were built for β-cyclodextrin using the 233-compound dataset available in the literature. These results demonstrate that the machine learning regression methods can successfully describe the complex formation between organic molecules and β-cyclodextrin or sulfobutylether-β-cyclodextrin. In particular, the root mean square errors for the test sets predictions by the best models are low, 1.9 and 2.7kJ/mol, respectively. The developed QSPR models can be used to predict the solubilizing effect of cyclodextrins and to help prioritizing experimental work in drug discovery.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21497190     DOI: 10.1016/j.ijpharm.2011.03.065

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  Inclusion Complex of Isoliquiritigenin With Sulfobutyl Ether-β-Cyclodextrin: Preparation, Characterization, Inclusion Mode, Solubilization, and Stability.

Authors:  Xiaozheng Wu; Jiamin Li; Chunmei Hu; Yingying Zheng; Yufei Zhang; Jianping Li; Mengyue Li; Di Xiao; Li Lu; Yuechang Huang; Xingmin Zhang; Chen Li
Journal:  Front Chem       Date:  2022-06-21       Impact factor: 5.545

2.  Predicting complexation performance between cyclodextrins and guest molecules by integrated machine learning and molecular modeling techniques.

Authors:  Qianqian Zhao; Zhuyifan Ye; Yan Su; Defang Ouyang
Journal:  Acta Pharm Sin B       Date:  2019-05-08       Impact factor: 11.413

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.